Biocryst Pharmaceuticals buy Wedbush
Start price
30.06.25
/
50%
€7.60
Target price
30.06.26
€15.36
Performance (%)
6.79%
Price
11:40
€8.12
Summary
This prediction is currently active. With a performance of 6.79%, the BUY prediction by Wedbush for Biocryst Pharmaceuticals is trending in the right direction. This prediction currently runs until 30.06.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -4.554% | -4.554% |
| iShares Core DAX® | 0.444% | 3.030% |
| iShares Nasdaq 100 | 3.819% | 4.073% |
| iShares Nikkei 225® | 1.148% | 6.904% |
| iShares S&P 500 | 2.371% | 2.677% |
Comments by Wedbush for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Wedbush from $16.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Wedbush for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.80
25.02.25
25.02.25
€14.28
25.02.26
25.02.26
-19.22%
26.02.26
26.02.26
